Financials
- Market Capitalization 120.89 B
- Employee 6 400
- Founded 1989
- CEO Reshma Kewalramani
- Website www.vrtx.com
- Headquarter Massachusetts, United States
- FIGI BBG000C1S2X2
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
26.5
Rapporto prezzo/fatturato
9.42
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 244 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 656.12 USD | -1.05% | -1.94% | +6.50% | +19.28% | 68.79 B USD | ||
| 301 | ARGX argenx SE - American Depositary Shares | 859.43 USD | -1.92% | -5.99% | -2.54% | +53.93% | 53.18 B USD | ||
| 375 | RVMD Revolution Medicines, Inc. - Common Stock | 184.97 USD | +0.55% | -2.65% | +17.03% | +233.88% | 39.32 B USD | ||
| 387 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 281.26 USD | -2.36% | -11.69% | -2.38% | -9.64% | 37.55 B USD |